Pollard M, Luckert P H
J Natl Cancer Inst. 1986 Aug;77(2):583-7.
More than 50% of Lobund-Wistar (L-W) strain rats developed large, palpable prostate adenocarcinomas (PAs) following treatments with N-nitroso-N-methylurea (CAS: 684-93-5) and testosterone propionate [(TP) CAS: 57-85-2], and most of the tumor-bearing rats manifested metastatic lesions. The incubation periods averaged 10.6 months. Within the same timeframe, no L-W rat developed a similar palpable PA when treated only with TP. In L-W rats, TP acted as a tumor enhancement agent, with primary emphasis on the development of prostate cancer.
超过50%的Lobund-Wistar(L-W)品系大鼠在接受N-亚硝基-N-甲基脲(CAS:684-93-5)和丙酸睾酮[(TP)CAS:57-85-2]治疗后,出现了可触及的大型前列腺腺癌(PA),并且大多数荷瘤大鼠出现了转移病灶。潜伏期平均为10.6个月。在同一时间段内,仅用TP治疗的L-W大鼠未出现类似的可触及PA。在L-W大鼠中,TP起到肿瘤增强剂的作用,主要促进前列腺癌的发展。